Assyro AI

Orange Book product · Brand (NDA)

TEKTURNA

ALISKIREN HEMIFUMARATE

Brand (NDA)NDA 021985TE ABRX LXO IRELAND

At a glance

Mar 05, 2007

Approved

Brand (NDA)

Application

AB

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 05, 2007

    19 yr 7 mo ago

  2. Patent 8617595 expires

    Listed drug product patent expiration.

    Feb 19, 2026

    4 mo ago

  3. Today

  4. Patent 8617595*PED expires

    Listed listed patent expiration.

    Aug 19, 2026

    in 2 mo

Pharmaceutical detail

Active ingredient

ALISKIREN HEMIFUMARATE

Strength

EQ 150MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 021985

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8617595Feb 19, 20264 mo ago
Product
8617595*PEDAug 19, 2026in 2 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.